ArticleCell death & disease2026

β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1.

Huan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.